Hematologic Cancers

Orelabrutinib Plus RCHOP Effective for Extranodal, Non-GCB Diffuse Large B-Cell Lymphoma

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date October 6, 2022

The aim of this trial was to evaluate the efficacy and safety of orelabrutinib with RCHOP in patients with extranodal non-GCB DLBCL.

PLM60 Plus Pegaspargase Shows Promise in Extranodal Natural Killer and T-Cell Lymphoma

By

Jonathan Goodman, MPhil

Publish Date October 5, 2022

Researchers sought to determine whether PLM60 with pegaspargase would have efficacy in patients with extranodal natural killer/T-cell lymphoma.

Cladribine Induces Long-Term, Durable Responses in Hairy Cell Leukemia

By

Jonathan Goodman, MPhil

Publish Date October 4, 2022

Researchers sought to determine the long-term efficacy of cladribine in patients with hairy cell leukemia.

Genomic Features and Anti-CD19 CAR-T Therapy Failure in Large B-Bell Lymphoma

By

Vicki Moore, PhD

Publish Date October 3, 2022

Researchers sought to identify genomic features in patients with large B-cell lymphoma that are linked with anti-CD19 CAR-T therapy.

Cutaneous T-Cell Lymphoma Incidence on the Rise in the United States

By

Leah Lawrence

Publish Date October 3, 2022

The incidence of cutaneous T-cell lymphoma in the United States increased from 2000 to 2018, with an annual percent change of 0.61%.